Back To Search Results

Physiology, Cardiac Index

Editor: Amgad N. Makaryus Updated: 6/8/2024 8:56:01 AM

Introduction

The human heart is among life's most studied and vital organs, and numerous methods exist to delineate the function and health status. One such measure of heart function is the cardiac index, which relies on another important parameter—cardiac output. This output converts to a normalized value that accounts for the patient's body size.

For example, an individual's cardiac output with a body weight of 120 pounds (54 kg) may contrast with a person whose body weight is 220 pounds (100 kg). Cardiac output as a sole parameter cannot reliably indicate or determine cardiac performance. Calculating the cardiac index helps solve this problem.

The equation for the cardiac index is mentioned below and is denoted in units of (L/min)/(m2):

Cardiac index = cardiac output/body surface area (BSA) = (heart rate x stroke volume)/BSA

Cellular Level

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Cellular Level

Cardiac output (CO) is further determined by stroke volume (SV), which is the blood volume ejected by a heartbeat, and heart rate (HR), which is the number of heartbeats per minute. Specifically, this metric measures left ventricular output and is a clinical indicator of left ventricular function. Conditions that affect heart rate or SV directly affect cardiac output. Heart rate is influenced by multiple factors, including neuronal and hormonal input (eg, norepinephrine, epinephrine, acetylcholine, and thyroid hormones), ion concentrations (eg, Ca2+ and K+), body temperature, chemoreception (ie, blood oxygen levels, blood CO2 levels, and pH), and drugs (eg, β-blockers, muscarinic antagonists, and digitalis). SV is affected by 3 variables—contractility, afterload, and preload.[1]

At the cellular level, autonomic nerve activity or myocardial stretch alterations affect cardiac output by slightly different mechanisms. To increase the heart rate, the autonomic nervous system increases sympathetic innervation and reduces vagal tone to the sinoatrial node. In addition, sympathetic fibers directly influence the adrenal medulla, prompting the release of catecholamines, predominantly epinephrine and norepinephrine. These neuronal and hormonal catecholamines influence β1-adrenergic receptors of the heart, leading to increased contractility and heart rate.[2][3][4]

Discrete increases in the stretch of the myocardium, or increases in preload, also increase cardiac output by augmenting the relationship between myofibril and Ca2+ binding. The term preload derives from the temporal association with the myocardium being pre-contraction, representing the load on the heart during diastole or the filling cycle. Specifically, stretching the muscle fibers is believed to increase troponin's affinity for calcium and decrease the space between thick and thin filaments of the cardiac muscle, increasing cross-bridges. This elevation in SV boosts cardiac output. However, the precise underlying mechanism remains a subject of ongoing debate.[5][6][7]

Another variable that profoundly impacts cardiac output is afterload, aptly named due to the temporal relationship with the heartbeat. Afterload refers to the load or resistance against which the heart must pump, or conversely, the pressure in the aorta that the heart needs to overcome to eject left ventricular volume, or preload. Clinical scenarios characterized by increased afterload include hypertension and aortic valve stenosis. An elevation in afterload reduces SV, whereas an increase in contractility or preload results in an augmented SV.[8]

Organ Systems Involved

The organ systems involved include:

  • Primary system: This comprises the cardiovascular system.
  • Secondary systems: This comprises the autonomic nervous system, the endocrine system, and the vascular system.

Function

The function of the cardiac index is to create a normalized value for the cardiac function, adjusting for the patient's body size. The heart's objective is to maintain blood circulation at an adequate volume to fulfill the body's metabolic demands. Cardiac output varies depending on body size and activity level. Generally, the cardiac output at rest falls within a range of 4 to 8 L/min, averaging around 5 L/min. During intense physical activity, elite athletes can achieve cardiac outputs as high as approximately 40 L/min. The normal cardiac index value should range between 2.5 and 4 L/min/m2. A value less than 2 should raise suspicion for cardiogenic shock, characterized by <2.2 L/min/m2 with support or <1.8 L/min/m2 without support.[9][10]

Related Testing

Clinicians have a few options for assessing the cardiac index. Depending on the specific circumstances, necessity, and severity of the patient's condition, a clinician can select from a range of options to best meet the patient's requirements. These options range from noninvasive imaging techniques to highly invasive pressure readings. Noninvasive procedures are readily accessible and can provide accurate values, with limited evidence suggesting that their benefits outweigh the risks and complications associated with invasive procedures. Considering the lack of a gold standard for measuring cardiac output and index, caution is recommended when selecting tests. This decision should involve consideration of testing motives, goals, and the patient's condition.[11][12]

Cardiac Output

Noninvasive imaging techniques

  • Doppler ultrasound: Using a specialized probe, an ultrasound machine gauges the Doppler shift in returning ultrasound waves to determine blood flow rate and volume and assess the cardiac index. The benefits of Doppler ultrasound include affordability, fast results, and noninvasive nature. However, the drawback lies in the high dependency on operator proficiency.
  • Echocardiogram: The echocardiogram uses 2-dimensional ultrasound and Doppler shift measurements to analyze blood flow rate and volume. This method is noninvasive and accurate when performed by trained professionals. However, the drawbacks include high cost and reliance on operator skills.
  • Modified CO2 Fick method: This method applies the Fick principle and measures changes in CO2 elimination and end-tidal CO2, indicative of atrial CO2. The main advantage is providing comparable accuracy to invasive methods. However, the method is limited to patients under mechanical ventilation and lacks measurement of preload indexes, similar to other noninvasive techniques.
  • Cardiac Magnetic Resonance Imaging (MRI): A cardiac MRI offers a comprehensive evaluation of cardiovascular diseases, including cardiomyopathy, ischemic heart disease, congenital anomalies, valvular disorders, and pericardial diseases. This imaging modality uses high-definition flow imaging to quantify blood flow and velocities across chambers, valves, and shunts. Besides diagnosing cardiac conditions, cardiac MRI accurately assesses left ventricular function and cardiac output or index.[13]

Invasive techniques

  • The oxygen Fick method: This method uses the Fick equation (VO2)/(CaO2−CvO2) to calculate the cardiac output numerically. The individual variables, typically pulmonary artery catheterization (PAC), are measured via invasive procedures. Although providing exceptional precision, the method is invasive, time-consuming, and carries risks of infection, arrhythmias, and pulmonary artery disruption.
  • Lithium dilution cardiac output: This technique measures cardiac output by utilizing a specialized sensor connected to an existing arterial line, central line, or peripheral venous line. Following the placement of the line, intravenous injection of lithium chloride ensues, and a lithium-sensitive electrode generates a lithium dilution curve for deriving cardiac output. Multiple studies indicate the necessity of averaging 3 lithium dilution measurements for accurate cardiac output assessment.[14][15]

FloTrac

The FloTrac is a minimally invasive device used in an acute care setting. The device utilizes arterial line waveform analysis to monitor hemodynamic parameters, updating every 20 seconds. These parameters include CO/cardiac index, SV, stroke volume variation, and systemic vascular resistance (SVR). This device utilizes a specialized sensor that attaches to an inserted arterial line to obtain pressure readings. Although the FloTrac device offers a valuable means of assessing real-time hemodynamic status in critically ill patients post-therapeutic interventions or clinical course changes, reliance on data has drawbacks. For instance, readings are inaccurate in patients with advanced liver disease, septic shock, and conditions causing decreased vascular tone. Similarly, accuracy diminishes in patients with low cardiac output (cardiac index <2.2 L/min/m2), as a low cardiac output state can lead to a high systemic vascular resistance index, resulting in inaccuracies in pressure readings.[16][17]

Body Surface Area

Among the methods available for calculating the body surface area (BSA), the Mosteller formula is frequently utilized, which is expressed as:

BSA = The square root of (bodyweight [kg[ x height [cm] / [3600])

The average BSA for adult men is 1.9 and 1.6 for women. Smartphone applications can calculate BSA for patients; however, caution must be exercised to select the appropriate equation for the clinical encounter and patient.[18] 

Pathophysiology

The pathophysiology of cardiac index primarily stems from dysfunctions within the heart, which can be categorized into systolic and diastolic dysfunctions.

  • Systolic dysfunctions: Systolic dysfunctions, characterized by a failure to pump effectively, can arise from various conditions, including
    • High blood pressure (high afterload)
    • Cardiomyopathy 
    • Coronary artery disease 
    • Heart valve disease 
    • Other structural diseases, whether congenital or otherwise 
  • Diastolic dysfunctions: Diastolic dysfunctions, characterized by an inability to fill, resulting in secondary effects of other diseases, including
    • Hypertrophy 
    • Sequelae of complications associated with diabetes, hypertension, obesity, and physical inactivity
    • Other structural conditions, whether congenital or otherwise [19]

Clinical Significance

The clinical significance of the cardiac index arises from the measurement of cardiac function normalized to the patient's body habitus. Considering the diverse body types, clinicians can gain crucial insights into heart function. This understanding is pivotal as clinicians often need to make medication and treatment decisions and educate patients on prognosis based on these objective parameters. For example, bedside echocardiogram monitoring in patients with septic shock can inform the tailored administration of vasopressors and dilators. The cardiac index provides a comprehensive understanding of how the heart functions relative to the body rather than in isolation.[20]

The cardiac index is a hemodynamic measurement to evaluate the different forms of shock and circulatory disorders that lead to poor tissue perfusion.

The 4 forms of shock are listed below.

  • Cardiogenic: This shock stems from underlying heart dysfunction, such as myocardial infarction, arrhythmias, heart failure, cardiomyopathy, myocarditis, or severe mitral or aortic regurgitation.
    • Cardiac index in cardiogenic shock: decreased
    • SVR in cardiogenic shock: increased
  • Obstructive: This shock occurs due to obstruction of the heart or the great vessels, as seen in conditions such as cardiac tamponade, massive pulmonary embolism, or tension pneumothorax.
    • Cardiac index in obstructive shock: decreased
    • SVR in obstructive shock: decreased
  • Hypovolemic: This shock results from a loss of intravascular blood volume, which can occur due to hemorrhage or non-hemorrhagic fluid loss, such as diarrhea, vomiting, burns, third spacing, diuresis, or adrenal insufficiency.
    • Cardiac index in hypovolemic shock: decreased
    • SVR in hypovolemic shock: increased
  • Distributive: This shock arises from the redistribution of body fluid, often due to vasodilation with or without capillary leakage, such as septic or anaphylactic shock. 
    • Cardiac index in distributive shock: increased
    • SVR in distributive shock: decreased

A decrease in cardiac index is expected in cardiogenic, obstructive, and hypovolemic shock. In contrast, an increase in cardiac index in septic and anaphylactic shock is expected.[21]

Numerous studies have linked cardiac index to overall health. For instance, findings from the Framingham Heart Study revealed that individuals with a low cardiac index faced a heightened risk of developing dementia.[22] Another study examining cardiac index among organ donors identified a lower likelihood of 1-year mortality in recipients of hearts from donors with a higher cardiac index (>3.7 L/min/m2).[23]

References


[1]

Vincent JL. Understanding cardiac output. Critical care (London, England). 2008:12(4):174. doi: 10.1186/cc6975. Epub 2008 Aug 22     [PubMed PMID: 18771592]

Level 3 (low-level) evidence

[2]

Kovacs G, Avian A, Olschewski A, Olschewski H. Zero reference level for right heart catheterisation. The European respiratory journal. 2013 Dec:42(6):1586-94. doi: 10.1183/09031936.00050713. Epub 2013 Jun 21     [PubMed PMID: 23794468]

Level 2 (mid-level) evidence

[3]

Swan HJ, Ganz W, Forrester J, Marcus H, Diamond G, Chonette D. Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. The New England journal of medicine. 1970 Aug 27:283(9):447-51     [PubMed PMID: 5434111]


[4]

Fisher JP. Autonomic control of the heart during exercise in humans: role of skeletal muscle afferents. Experimental physiology. 2014 Feb:99(2):300-5. doi: 10.1113/expphysiol.2013.074377. Epub 2013 Aug 30     [PubMed PMID: 23995102]

Level 3 (low-level) evidence

[5]

Arnsdorf MF. The cellular basis of cardiac arrhythmias. A matrical perspective. Annals of the New York Academy of Sciences. 1990:601():263-80     [PubMed PMID: 2221691]

Level 3 (low-level) evidence

[6]

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). Journal of the American College of Cardiology. 2018 Oct 30:72(18):2231-2264. doi: 10.1016/j.jacc.2018.08.1038. Epub 2018 Aug 25     [PubMed PMID: 30153967]


[7]

Sequeira V, van der Velden J. The Frank-Starling Law: a jigsaw of titin proportions. Biophysical reviews. 2017 Jun:9(3):259-267. doi: 10.1007/s12551-017-0272-8. Epub 2017 Jun 21     [PubMed PMID: 28639137]


[8]

Petersen DA. Plunging into preload and afterload. Dimensions of critical care nursing : DCCN. 2001 May-Jun:20(3):32-6     [PubMed PMID: 22076396]


[9]

Reddy YNV, Melenovsky V, Redfield MM, Nishimura RA, Borlaug BA. High-Output Heart Failure: A 15-Year Experience. Journal of the American College of Cardiology. 2016 Aug 2:68(5):473-482. doi: 10.1016/j.jacc.2016.05.043. Epub     [PubMed PMID: 27470455]


[10]

Lavie CJ, Arena R, Swift DL, Johannsen NM, Sui X, Lee DC, Earnest CP, Church TS, O'Keefe JH, Milani RV, Blair SN. Exercise and the cardiovascular system: clinical science and cardiovascular outcomes. Circulation research. 2015 Jul 3:117(2):207-19. doi: 10.1161/CIRCRESAHA.117.305205. Epub     [PubMed PMID: 26139859]


[11]

Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD, American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2014 Jun 10:63(22):e57-185. doi: 10.1016/j.jacc.2014.02.536. Epub 2014 Mar 3     [PubMed PMID: 24603191]

Level 1 (high-level) evidence

[12]

Godley RW, Green D, Dillon JC, Rogers EW, Feigenbaum H, Weyman AE. Reliability of two-dimensional echocardiography in assessing the severity of valvular aortic stenosis. Chest. 1981 Jun:79(6):657-62     [PubMed PMID: 7226954]


[13]

Rajiah PS, François CJ, Leiner T. Cardiac MRI: State of the Art. Radiology. 2023 May:307(3):e223008. doi: 10.1148/radiol.223008. Epub 2023 Apr 11     [PubMed PMID: 37039684]


[14]

Li T, Cai H, Pan H, Pu Q. Cardiac output measurement using a modified carbon dioxide Fick method: comparison analysis with pulmonary artery catheter method and pulse induced contour cardiac output method. International journal of clinical and experimental medicine. 2015:8(3):3530-7     [PubMed PMID: 26064245]


[15]

Jonas MM, Tanser SJ. Lithium dilution measurement of cardiac output and arterial pulse waveform analysis: an indicator dilution calibrated beat-by-beat system for continuous estimation of cardiac output. Current opinion in critical care. 2002 Jun:8(3):257-61     [PubMed PMID: 12386506]

Level 3 (low-level) evidence

[16]

Argueta E, Berdine G, Pena C, Nugent KM. FloTrac® monitoring system: what are its uses in critically ill medical patients? The American journal of the medical sciences. 2015 Apr:349(4):352-6. doi: 10.1097/MAJ.0000000000000393. Epub     [PubMed PMID: 25584624]


[17]

Maeda T, Yoshitani K, Inatomi Y, Ohnishi Y. Inaccuracy of the FloTrac/Vigileo™ system in patients with low cardiac index. Journal of cardiothoracic and vascular anesthesia. 2014 Dec:28(6):1521-6. doi: 10.1053/j.jvca.2014.04.013. Epub 2014 Oct 11     [PubMed PMID: 25306519]


[18]

Redlarski G, Palkowski A, Krawczuk M. Body surface area formulae: an alarming ambiguity. Scientific reports. 2016 Jun 21:6():27966. doi: 10.1038/srep27966. Epub 2016 Jun 21     [PubMed PMID: 27323883]


[19]

Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct 15:128(16):1810-52. doi: 10.1161/CIR.0b013e31829e8807. Epub 2013 Jun 5     [PubMed PMID: 23741057]

Level 3 (low-level) evidence

[20]

Abdalaziz FA, Algebaly HAF, Ismail RI, El-Sherbini SA, Behairy A. The use of bedside echocardiography for measuring cardiac index and systemic vascular resistance in pediatric patients with septic shock. Revista Brasileira de terapia intensiva. 2018 Oct-Dec:30(4):460-470. doi: 10.5935/0103-507X.20180067. Epub     [PubMed PMID: 30672970]


[21]

Lee EP, Hsia SH, Lin JJ, Chan OW, Lee J, Lin CY, Wu HP. Hemodynamic Analysis of Pediatric Septic Shock and Cardiogenic Shock Using Transpulmonary Thermodilution. BioMed research international. 2017:2017():3613475. doi: 10.1155/2017/3613475. Epub 2017 Mar 16     [PubMed PMID: 28401152]


[22]

Jefferson AL, Beiser AS, Himali JJ, Seshadri S, O'Donnell CJ, Manning WJ, Wolf PA, Au R, Benjamin EJ. Low cardiac index is associated with incident dementia and Alzheimer disease: the Framingham Heart Study. Circulation. 2015 Apr 14:131(15):1333-9. doi: 10.1161/CIRCULATIONAHA.114.012438. Epub 2015 Feb 19     [PubMed PMID: 25700178]


[23]

Pasrija C, Kon ZN, Shah A, Holmes SD, Rozenberg KS, Joseph S, Griffith BP. Indexed donor cardiac output for improved size matching in heart transplantation: A United Network for Organ Sharing database analysis. JTCVS open. 2023 Sep:15():291-299. doi: 10.1016/j.xjon.2023.04.021. Epub 2023 May 12     [PubMed PMID: 37808019]